About IVAX Diagnostics
IVAX Diagnostics is a company based in Miami (United States) founded in 2001 was acquired by Erba Mannheim in September 2010. IVAX Diagnostics operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter Miami, United States
- SectorsHealthcare
- Website ivaxdiagnostics.com
- Acquired by Erba Mannheim (Sep 2010)
- Investors
- Acquired byErba Mannheim
(Sep 2010)
Investors in IVAX Diagnostics
IVAX Diagnostics has secured backing from 1 investor. Prominent investors backing the company include Erba Mannheim.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Erba provides diagnostic solutions for healthcare needs worldwide through research and development. | 1999 | erbamannheim.com | Mannheim, Germany |
Investor details for IVAX Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of IVAX Diagnostics
2 dated milestones of IVAX Diagnostics across 9 years, from founding to its latest funding, stage changes and deals.
- Founded IVAX Diagnostics is founded.
- Exit Acquired by Erba Mannheim.
Competitors of IVAX Diagnostics
IVAX Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bio-rad.com | 1952 | Hercules, United States | – | 10 | Portfolio of products and services for life science research and clinical diagnostic markets | |
| siemens-healthineers.com | 1847 | Erlangen, Germany | – | 66,000 | AI-based medical diagnostics are developed for healthcare applications. | |
| merckgroup.com | 1668 | Darmstadt, Germany | – | 922 | Merck is engaged in science and technology solutions globally. | |
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| biolifesolutions.com | 1987 | Bothell, United States | – | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | |
| apbiocode.com | 2008 | Santa Fe Springs, United States | $20.29M | 66 | Assay kits and instruments for in vitro diagnostics are developed. | |
| telesisbio.com | 2013 | San Diego, United States | $25M | – | Online platform offering life sciences reagents and kits |
Detailed competitors of IVAX Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to IVAX Diagnostics
10 companies that operate in the same segment as IVAX Diagnostics (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IVAX Diagnostics
IVAX Diagnostics was founded in 2001.
IVAX Diagnostics is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Founded in 2001 in Miami, United States, the company operates in the medical diagnostics sector. Proprietary diagnostic reagents, test kits, and instrumentation are manufactured and marketed, focusing on autoimmune disorders, chemistry, hematology, diabetes, and infectious diseases. These products support detection and analysis in clinical settings across various healthcare applications.
IVAX Diagnostics's top competitors include Biocare Medical, Merck and Siemens Healthineers.
IVAX Diagnostics has 1 investor. Key investors include Erba Mannheim.
Yes. IVAX Diagnostics was acquired by Erba Mannheim in September 2010.